ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2853

The Pattern of Musculoskeletal Complaints in Patients with Suspected Psoriatic Arthritis and Their Correlation with Physical Examination and Ultrasound

Samantha Sarabia 1, Chandra Farrer 2, Jensen Yeung 3, Richard Cook 4, Ker-Ai Lee 5, Dana Jerome 3 and Lihi Eder6, 1Faculty of Medicine, Queens University, Kingston, Canada, 2University of Toronto, Toronto, Canada, 3University of Toronto, Toronto, 4University of Waterloo, Waterloo, Canada, 5University of Waterloo, Waterloo, 6Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: diagnosis and epidemiologic methods, Psoriatic arthritis, seronegative spondyloarthropathy, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: 5T116: Spondyloarthritis Including Psoriatic Arthritis – Clinical VI: Psoriatic Arthritis Clinical Studies (2852–2857)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: There is limited information about the constellation of musculoskeletal symptoms experienced by patients with early psoriatic arthritis (PsA). This study aims to describe the pattern of musculoskeletal symptoms and their correlation with clinical and sonographic findings among psoriasis patients with suspected PsA.

Methods: The study evaluated patients with psoriasis and musculoskeletal complaints who did not have a prior diagnosis of PsA. These patients were evaluated in a rapid access clinic that included a central triage system using the following modalities: 1) screening questionnaires that included homunculus where patients marked the location of the affected joints, 2) assessment by an advanced practice physiotherapist, 3) musculoskeletal ultrasound (MSK-US) of joints and entheses. In addition, patients completed questionnaires about the nature and duration of their musculoskeletal symptoms, physical function and quality of life. All patients were then assessed by a rheumatologist who classified each patient to: “PsA”, “Not PsA”, or “Possibly PsA”. Agreement between modalities was assessed using Kappa statistics.

Results: 203 patients with psoriasis and musculoskeletal symptoms were enrolled in the study.  18 (8.8%) and 48 (23.6%) were classified as “PsA and “possible PsA”, respectively. There was no difference between the two groups in the presence, distribution and duration of musculoskeletal pain (Table 1). Patients with PsA had higher intensity of musculoskeletal and skin-related symptoms (DLQI) and worse scores in domains such as physical function (HAQ), quality of life (PSAID) and fatigue (FACIT). Patients who were classified as “PsA” were more likely to use systemic medications for psoriasis (< 0.05), have severe psoriasis (p=0.02) and nail lesions (p=0.02) and have synovitis/enthesitis by MSK-US (p=0.01). Patients with positive MSK-US inflammation were older (p< 0.001), reported more joint stiffness (p=0.02) and physical dysfunction (by HAQ, p=0.02, Table 2), irrespective of the clinical diagnosis. Analysis of agreement between modalities revealed the strongest agreement between the rheumatologist and physiotherapist (k=0.28, Table 3). The lowest levels of agreement were found between ultrasound and patient (k=0.08) and physiotherapist and ultrasound (k=0.08).

Conclusion: The intensity, rather than the type, duration or distribution of musculoskeletal symptoms, is associated with psoriatic arthritis among patients with psoriasis. The correlation between musculoskeletal symptoms, patient reported outcomes and sonographic findings is poor in patients with suspected PsA. MSK-US provides additional information to the clinical assessment and aid in diagnosing PsA patients at earlier stages.


Table 1

Table 1 – Musculoskeletal symptoms and patient reported outcomes by disease status


Table 2

Table 2 – Comparison of patient characteristics by ultrasound inflammation -at least 1 joint or entheseal site with positive Doppler-


Table 3

Table 3 – Agreement between methods of joint/enthesis assessment -50 tender or swollen joints on physical examination, the presence of positive Doppler on ultrasound-


Disclosure: S. Sarabia, None; C. Farrer, None; J. Yeung, None; R. Cook, None; K. Lee, None; D. Jerome, None; L. Eder, Abbvie, 2, 5, 8, Celgene, 5, Janssen, 5, Lily, 2, 5, Novartis, 2, 5, Pfizer, 2, 8, UCB, 2.

To cite this abstract in AMA style:

Sarabia S, Farrer C, Yeung J, Cook R, Lee K, Jerome D, Eder L. The Pattern of Musculoskeletal Complaints in Patients with Suspected Psoriatic Arthritis and Their Correlation with Physical Examination and Ultrasound [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-pattern-of-musculoskeletal-complaints-in-patients-with-suspected-psoriatic-arthritis-and-their-correlation-with-physical-examination-and-ultrasound/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-pattern-of-musculoskeletal-complaints-in-patients-with-suspected-psoriatic-arthritis-and-their-correlation-with-physical-examination-and-ultrasound/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology